Swipe om te navigeren naar een ander artikel
The work was performed at Pneumology and Endocrinology-Nutrition Services, Carlos Haya University Hospital, Malaga, Spain.
Bronchiectasis causes pulmonary infections and loss of lung function, resulting in chronic respiratory symptoms and worsening health-related quality of life. The aims of this study were to measure symptoms of depression and anxiety in a sample of patients with bronchiectasis and evaluate their relationship to health outcomes and health-related quality of life.
This cross-sectional study included adolescents and adults with bronchiectasis. Patients completed the hospital anxiety and depression scale and the St. George respiratory questionnaire. Health outcome data, including clinical, radiological and spirometric values, were recorded from medical charts.
Ninety-three participants with bronchiectasis of any aetiology were recruited: 20 % had elevated depression-related scores and 38 % had elevated anxiety-related scores. Increased symptoms of depression and anxiety were significantly associated with age; anxiety was associated with more frequent exacerbations. Regression analyses indicated that after controlling for demographic (gender and age) and clinical variables (exacerbations frequency, daily sputum, aetiology and spirometry), both depression and anxiety symptoms predicted significantly worse health-related quality of life. In comparison with other predictors, psychological symptoms explained the largest amount of variance in health-related quality of life.
Symptoms of depression and anxiety were significant predictors of health-related quality of life in patients with bronchiectasis, independently of respiratory involvement, gender, age or other variables.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Floto, R. A. & Haworth, C. S. (Eds.) (2011). Bronchiectasis. European Respiratory Society Monograph. doi: 10.1183/1025448x.10005111.
Abbott, J., Hart, A., Morton, A., & Gee, L. (2008). Conway S. Health-related quality of life in adults with cystic fibrosis: The role of coping. Journal of Psychosomatic Research.
US Food and Drug Administration (2009). Guidance for industry patient-reported outcome. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
Martínez-García, M. A., Perpiñá Tordera, M., Román Sánchez, P., & Soler Cataluña, J. J. (2005). Internal consistency and validity of the Spanish version of the St. George’s respiratory questionnaire for use in patients with clinically stable bronchiectasis. Archivos de Bronconeumologia, 41, 110–117. PubMedCrossRef
Martínez-García, M. A., Perpiñá-Tordera, M., Román-Sánchez, P., & Soler-Cataluña, J. J. (2005). Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest, 128(739–45), 12.
U.S. Preventive Task Force (2009). Screening for depression in adults: U.S. Preventive services task force recommendation stastement. Annals of Internal Medicine 151:784–792.
Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., et al. (2004). Disability and quality of life impact of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatrica Scand., 109, 38–46. CrossRef
Haro, J. M., Palacín, C., Vilagut, G., Martínez, M., Bernal, M., Luque, I., et al. (2006). Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-España. Medical Clinics (Barc), 126, 445–451. CrossRef
Roca, J., Sanchis, J., Agustí Vidal, A., Segarra, F., Navajas, D., Rodriguez-Roisin, R., et al. (1986). Spirometric reference values for a Mediterranean population. Bulletin Européen de Physiopathologie Respiratoire, 22, 217–224. PubMed
Bhalla, M., Turcios, N., Aponte, V., Jenkins, M., Leitman, B. S., McCauley, D. I., et al. (1991). Cystic fibrosis: Scoring system with thin-section CT. Radiology, 179, 783–788. PubMed
ATS statement. (2002). Guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 66:111–117.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scand., 67, 361–370. CrossRef
Quittner AL, Cruz I, Blackwell LS, Schechter MS. (2010). The international depression and anxiety epidemiological study (TIDES): Preliminary results from the United States. Pediatric Pulmonology, 45(Suppl. 33), 445S.
Quittner, A. L., Cruz, I., & Marciel, K. K. (2009). A new PRO for non-CF bronchiectasis: Associations between the QOL-B and health outcomes. [Abstract]. European Respiratory Journal, 34(Suppl. 53), 1010S.
- Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life
Alexandra L. Quittner
- Springer Netherlands